Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND AcceptancePRNewsWire • Thursday
Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell TechnologyPRNewsWire • Monday
Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 GoalsPRNewsWire • 11/05/26
Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026PRNewsWire • 10/29/26
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management BoardPRNewsWire • 10/15/26
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical StudiesPRNewsWire • 09/09/26
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid TumorsPRNewsWire • 09/02/26
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory DiseasesPRNewsWire • 08/06/26
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168Business Wire • 08/03/26
Evotec Selects Navan to Unify Global Travel, Payments, and Expense ManagementBusiness Wire • 07/23/26
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 OutlookPRNewsWire • 07/13/26
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for BiologicsPRNewsWire • 06/30/26
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with AlmirallAccesswire • 05/04/26